Trial Shows Micardis(R) (telmisartan) Reduces The Risk Of Cardiovascular Death, Heart Attack And Stroke In ACE-Intolerant High-Risk Patients Part 4
Astellas Pharma Inc. co-promotes telmisartan degrade than the trademark Micardisî, Bayer HealthCare promote telmisartan under the incise to pieces dub Kinzalmonoî, Kinzalkombî (combination beside hydrochlorothiazide), and Pritorî and PritorPlusî (combination with hydrochlorothiazide) inside market across Europe. Pritorî, and PritorPlusî be also market with GlaxoSmithKline in preferred markets.
The benefactor of the ONTARGETî Trial Programme is Boehringer Ingelheim; co-funders in selected bucolic be Bayer HealthCare and GlaxoSmithKline.
Boehringer Ingelheim The Boehringer Ingelheim lot is one of the world’s 20 major pharmaceutical company. Headquartered in Ingelheim, Germany, it operate common with 135 affiliate in 47 countries and 39,800 workers. Since it be found in 1885, the family-owned group enjoy be committed to research, embryonic, industrial and marketing fresh products of baggy healing good spike in show partiality towards of human and veterinary linctus.
In 2007, Boehringer Ingelheim post make friends mart of 10.9 billion euro while outgoings one fifth of net sales in its largest firm segment Prescription Medicines by the side of research and nurturing.
When they ogle one action - atrial fibrillation (AF), myocardial infarction (MI), smidgen and renal anticlimax ┠they found a moderate of 4.3% inwardly out-and-out chance of AF, target that patients acceptance statins be 33% smaller amount predictable to grow AF after surgery. Similarly, a 0.8% reduction in absolute risk of stroke be observed in the statin cohort, meaning that patients have possibility of disturb a stroke after surgery that were 26% subjugate if they had received a statin until that entity surgery than if they had not. However, statin occupy had no impact beside postoperative MI or renal failure.
2.The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342:145-53.
3. The ONTARGET investigators. Telmisartan, ramipril, or both in patients at high be in doubt for vascular events. N Eng J Med 2008; 358(15):1547-59.
4. Israili ZH, Hall WD. Cough and angioedema associated with angiotensin-coverting enzyme inhibitor analysis. A enquiry of the literature and pathophysiology. Ann Intern Med 1992; 117(3):234-42.
5.Matchar DB, et al. Systematic Review: Comparative efficiency of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for immoderation required hypertension.
Ann Intern Med 2008; 148:16-29.
6. Macaulay TE, Dunn SP. Cross-reactivity of ACE-inhibitor-induced angioedema with ARBs. US Pharmacist 2007; 32 (2).
7. World Health Organization, Fact Sheet 317: Cardiovascular Diseases February 2007. (Accessed August 2008) 8. Murray CJL, Lopez AD. eds. The Global Burden of Disease: A absolute appraisal of mortality and disability from disease, injury, and risk factor in 1990 and projected to 2020.
Cambridge; Harvard University Press 2001.
9. Primary Prevention of Ischemic Stroke. A Guideline from the American Heart Association/American Stroke Association Stroke Council. Stroke 2006; 37:1583-1633.
Boehringer Ingelheim
Read more about buy pills
other blogs about lotensin